
DBV Technologies S.A.
DBV Technologies S.A. (DBVT)
WebsitePrice
Market cap
Next catalystExpected 2031VIASKIN Peanut Patch — THRIVE, infants ages 6–12 months · Enrollment completionCompany presentation ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved